(Q33809252)

29 July 2017

1 reference

title

Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness (English)

1 reference

29 July 2017

Manji HK

1

1 reference

29 July 2017

McNamara R

series ordinal

2

1 reference

29 July 2017

Chen G

series ordinal

3

1 reference

29 July 2017

Lenox RH

series ordinal

4

1 reference

29 July 2017

language of work or name

1 reference

1 December 1999

1 reference

Australian and New Zealand Journal of Psychiatry

29 July 2017

published in

1 reference

29 July 2017

volume

33 Suppl

1 reference

29 July 2017

page(s)

S65-83

1 reference

Lithium: a brake in the rising cost of mental illness.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Signal transduction pathways. Molecular targets for lithium's actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

A bimodal model of the mechanism of action of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium-discontinuation-induced refractoriness: preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Monoamine neurotransmitter interactions and the prediction of antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

G proteins: implications for psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Signal sorting and amplification through G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The role of G proteins in transmembrane signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Molecular machines integrate coincident synaptic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Disruption of phosphoinositide signalling by lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Neural and developmental actions of lithium: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Neurotransmitter receptors and phosphoinositide turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Chronic lithium treatment reduces norepinephrine-stimulated inositol phospholipid hydrolysis in rat cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Chronic lithium treatment prevents atropine-induced supersensitivity of the muscarinic phosphoinositide response in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Effects of lithium on brain adenyl cyclase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium and brain adenyl cyclase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium at therapeutic concentrations inhibits human brain noradrenaline-sensitive cyclic AMP accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The effect of long-term lithium treatment on reserpine-induced supersensitivity in dopaminergic and serotonergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The effect of repeated electroconvulsive shock treatment and chronic lithium feeding on the release of norepinephrine from rat cortical vesicular preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Effects of lithium and desimipramine on second messenger responses in rat hippocampus: relation to G protein effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Effects of lithium on receptor-mediated activation of G proteins in rat brain cortical membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Biochemical and functional evidence of supersensitive platelet alpha 2-adrenoceptors in major affective disorder. Effect of long-term lithium carbonate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Platelet alpha 2 adrenoreceptors are decreased in number after antidepressant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Activation of protein kinase C alters the interaction of alpha 2-adrenoceptors and the inhibitory GTP-binding protein (Gi) in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

'Crosstalk': a pivotal role for protein kinase C in modulating relationships between signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

GTP-binding proteins as possible targets for protein kinase C action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Regulation of neurotransmitter receptor desensitization by protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The mechanism of protein kinase C activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Chronic lithium administration alters a prominent PKC substrate in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium induces corticotropin secretion and desensitization in cultured anterior pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Down-regulation of protein kinase C is due to an increased rate of degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts. Isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Influence of lithium on second messenger accumulation in NG 108-15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Altered protein phosphorylation in the rat brain following chronic lithium and carbamazepine treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The MARCKS brothers: a family of protein kinase C substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Membrane association of the myristoylated alanine-rich C kinase substrate (MARCKS) protein. Mutational analysis provides evidence for complex interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Cloning and molecular characterization of the murine macrophage "68-kDa" protein kinase C substrate and its regulation by bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Comparative distribution of myristoylated alanine-rich C kinase substrate (MARCKS) and F1/GAP-43 gene expression in the adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

MARCKS deficiency in mice leads to abnormal brain development and perinatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Effect of reduced myristoylated alanine-rich C kinase substrate expression on hippocampal mossy fiber development and spatial learning in mutant mice: transgenic rescue and interactions with gene background

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The inhibition of phosphoinositide synthesis and muscarinic-receptor-mediated phospholipase C activity by Li+ as secondary, selective, consequences of inositol depletion in 1321N1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium and myo-inositol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Visualization of agonist-stimulated inositol phospholipid turnover in individual neurons of the rat cerebral cortex and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium treatment of affective disorders: effects of lithium on the inositol phospholipid and cyclic AMP signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The interaction of lithium with thyrotropin-releasing hormone-stimulated lipid metabolism in GH3 pituitary tumour cells. Enhancement of stimulated 1,2-diacylglycerol formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium-induced reduction in intracellular inositol supply in cholinergically stimulated parotid gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Anticonvulsants in the treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Enhanced protein kinase C activity and translocation in bipolar affective disorder brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Initiation and adaptation: a paradigm for understanding psychotropic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

A molecular and cellular theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Control of transcription factors by signal transduction pathways: the beginning of the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium stimulates gene expression through the AP-1 transcription factor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Valproate robustly enhances AP-1 mediated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Bcl-2 promotes regeneration of severed axons in mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Increase in AP-1 transcription factor DNA binding activity by valproic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Platelet membrane phosphatidylinositol-4,5-bisphosphate alterations in bipolar disorder--evidence from a single case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

The AML1/ETO fusion protein activates transcription of BCL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Programmed cell death and Bcl-2 protection in very low oxygen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Bcl-2 gene family in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.1999.00670.X

10.1111/J.1440-1614.1999.00670.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference